GlassScriptPhysician profile
David Timothy Cox
NPI 1861474231
$1,593.44
in general payments reported to CMS, 2019-2025
21 companies · $409 in 2025
The $409 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $534 · 2020: $95.57 · 2021: $87.82 · 2022: $155 · 2023: $117 · 2024: $195 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $720.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $281.41 | 2019-2025 | Zerbaxa, Dificid |
| Abbvie INC. | $166.05 | 2025 | |
| Gilead Sciences, INC. | $147.60 | 2019-2025 | |
| Shionogi INC | $146.20 | 2022-2025 | Fetroja |
| Paratek Pharmaceuticals, INC. | $138.84 | 2019-2025 | Nuzyra |
| Insmed, INC. | $138.18 | 2019-2025 | Brinsupri, Arikayce |
| Astellas Pharma US INC | $122.64 | 2019-2020 | |
| Viiv Healthcare Company | $96.44 | 2019-2025 | Cabenuva, Rukobia, Dovato |
| Janssen Products, LP | $59.95 | 2019 | |
| Napo Pharmaceuticals INC | $46.78 | 2019 | |
| Amgen INC. | $43.59 | 2024 | Prolia, Evenity |
| Janssen Biotech, INC. | $37.28 | 2019-2021 | |
| Cormedix INC. | $28.76 | 2025 | Defencath |
| Vanda Pharmaceuticals INC. | $26.46 | 2022 | |
| Jazz Pharmaceuticals INC. | $25.69 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynavax Technologies Corporation | $17.66 | 2023 | Heplisav-B |
| Tetraphase Pharmaceuticals, INC. | $15.64 | 2019 | |
| Bio Products Laboratory USA, INC. | $15.12 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.64 | 2021 | |
| Allergan, INC. | $13.30 | 2019 | |
| La Jolla Pharmaceutical Company | $11.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.